Impact Factor: 1.090
Ranked 61 out of 70 in Hematology; 194 out of 213 in Oncology and 85 out of 120 in Pediatrics
Our goal is to make Pediatric Hematology and Oncology the premier journal for the international community of clinicians and scientists who together aim to define optimal therapeutic strategies for children and young adults with cancer and blood disorders.
Pediatric Hematology and Oncology covers all aspects of research and patient management within the area of blood disorders and malignant diseases of childhood.
Submit your clinical studies as well as basic and translational research reports regarding cancer pathogenesis, genetics, molecular diagnostics, pharmacology, stem cells, molecular targeting, cellular and immune therapies. Papers with a focus on supportive care, late effects and on related ethical, legal, psychological, social, cultural, or historical aspects of these fields are also appreciated. Reviews on important developments in the field are welcome.We are also interested in articles that address research in diverse clinical settings, exceptional case studies/series that add novel insights into pathogenesis and/or clinical care, and reviews highlighting discoveries and challenges emerging from consortia and conferences.
Why publish in Pediatric Hematology & Oncology?
- Indexed in Medline
- Have your research validated by international experts in Pediatric Hematology/Oncology
- Increase your opportunities for future collaboration
- Share your research with 50 free e-prints and tips on promoting your article
- Immediately see the impact your research has in the community by tracking downloads, citations, and the Altmetric Score via My Authored Works
Ready to submit?
Submit via ScholarOne Manuscripts.
Not ready yet? For help preparing your manuscript see our Instructions for Authors.
- Co Editor-in-Chief: Carl E. Allen, Baylor College of Medicine Houston, Texas, USA
- Co Editor-in-Chief: Kirk R. Schultz, BC Children's Hospital and Research Institute Vancouver, Canada